Share on StockTwits

Illumina (NASDAQ:ILMN) Director Karin Eastham unloaded 6,000 shares of the stock on the open market in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $157.56, for a total value of $945,360.00. Following the transaction, the director now directly owns 9,826 shares of the company’s stock, valued at approximately $1,548,185. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

A number of research firms have recently commented on ILMN. Analysts at Ned Davis Research upgraded shares of Illumina from a “sell” rating to a “neutral” rating in a research note on Monday, April 28th. Separately, analysts at Maxim Group upgraded shares of Illumina from a “hold” rating to a “buy” rating in a research note on Wednesday, April 23rd. They now have a $205.00 price target on the stock. Finally, analysts at Bank of America reiterated a “buy” rating on shares of Illumina in a research note on Wednesday, April 23rd. They now have a $195.00 price target on the stock. Eight research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $144.34.

Shares of Illumina (NASDAQ:ILMN) traded up 0.57% during mid-day trading on Tuesday, hitting $159.58. 1,136,406 shares of the company’s stock traded hands. Illumina has a one year low of $66.11 and a one year high of $183.30. The stock has a 50-day moving average of $145.6 and a 200-day moving average of $137.7. The company has a market cap of $20.490 billion and a P/E ratio of 111.59. Illumina also saw a large drop in short interest in May. As of May 15th, there was short interest totalling 17,710,485 shares, a drop of 11.9% from the April 30th total of 20,100,661 shares. Currently, 14.0% of the company’s stock are short sold. Based on an average trading volume of 1,263,753 shares, the days-to-cover ratio is presently 14.0 days.

Illumina (NASDAQ:ILMN) last announced its earnings results on Tuesday, April 22nd. The company reported $0.46 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.45 by $0.01. The company had revenue of $421.00 million for the quarter, compared to the consensus estimate of $391.50 million. During the same quarter last year, the company posted $0.46 earnings per share. Illumina’s revenue was up 27.2% compared to the same quarter last year. Analysts expect that Illumina will post $2.16 EPS for the current fiscal year.

Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.